Cellbiotech's probiotic brand Duolac has achieved the top position in South Korea's probiotic exports for 13 consecutive years. The company continues to enhance the global competitiveness of K-probiotics based on its proprietary strains and technology.
On July 22, Cellbiotech announced that Duolac has maintained its status as the leading exporter of probiotics in South Korea for 13 years.
According to the Ministry of Food and Drug Safety's '2025 Food Production Performance Report,' the total export value of probiotics from South Korea last year was 72 billion won. Of this, Cellbiotech recorded an export performance of 29.1 billion won.
This achievement is particularly significant as it comes amid a trade deficit in the health functional food industry. Last year, South Korea's imports of health functional foods reached 1.4505 trillion won, while exports totaled 452.4 billion won, resulting in a trade deficit of approximately 1 trillion won.
Since the collection of related statistics began in 2013, Cellbiotech has consistently held the top position in probiotic exports. Over the past 13 years, the cumulative export value of probiotics from South Korea has reached 538.5 billion won, with Cellbiotech accounting for 26.88 billion won, or about 50% of the total.
Since 2000, the company has expanded its global market based on its self-developed Korean CBT probiotics and unique technology. It currently exports to 55 countries worldwide, including Denmark, Turkey, Singapore, and Mexico.
Cellbiotech's 'Dual Coating' technology protects live probiotics with a double coating of protein and polysaccharides, shielding them from stomach acid and bile salts while ensuring delivery to the intestines. According to the company, this technology has increased the survival rate of probiotics by up to 91.6%, demonstrating intestinal survival rates up to 221 times higher than non-coated probiotics in human trials.
Experts advise consumers to consider the strains used, the source of ingredients, the manufacturer, verification of stability, and research evidence such as human application tests when selecting probiotic products.
Cellbiotech is expanding its overseas business by supplying products tailored to the market environment and consumer characteristics of each country, based on its proprietary strains and dual coating technology. The company plans to strengthen not only finished product exports but also local partnerships and customized product development.
A Cellbiotech representative stated, "Maintaining the top export position for 13 consecutive years is a result of Duolac's competitiveness being continuously recognized in the global market. We will continue to enhance the competitiveness of K-probiotics based on our unique strain development and dual coating technology."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.